These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 35836810)
1. Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy. Ma Z; Zhang W; Dong B; Xin Z; Ji Y; Su R; Shen K; Pan J; Wang Q; Xue W Theranostics; 2022; 12(11):4965-4979. PubMed ID: 35836810 [No Abstract] [Full Text] [Related]
2. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Lu X; Horner JW; Paul E; Shang X; Troncoso P; Deng P; Jiang S; Chang Q; Spring DJ; Sharma P; Zebala JA; Maeda DY; Wang YA; DePinho RA Nature; 2017 Mar; 543(7647):728-732. PubMed ID: 28321130 [TBL] [Abstract][Full Text] [Related]
3. ATM/NEMO signaling modulates the expression of PD-L1 following docetaxel chemotherapy in prostate cancer. Wang Z; Zhang X; Li W; Su Q; Huang Z; Zhang X; Chen H; Mo C; Huang B; Ou W; Chen J; Zhao G; Chen L; Shao L J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34301812 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade. Wang M; Huang Y; Chen M; Wang W; Wu F; Zhong T; Chen X; Wang F; Li Y; Yu J; Wu M; Chen D J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37620043 [TBL] [Abstract][Full Text] [Related]
5. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma. Fitzgerald AA; Wang S; Agarwal V; Marcisak EF; Zuo A; Jablonski SA; Loth M; Fertig EJ; MacDougall J; Zhukovsky E; Trivedi S; Bhatia D; O'Neill V; Weiner LM J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34737215 [TBL] [Abstract][Full Text] [Related]
6. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation. Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380 [TBL] [Abstract][Full Text] [Related]
7. Carbon ion irradiation induces DNA damage in melanoma and optimizes the tumor microenvironment based on the cGAS-STING pathway. Guo Y; Shen R; Wang F; Wang Y; Xia P; Wu R; Liu X; Ye W; Tian Y; Wang D J Cancer Res Clin Oncol; 2023 Aug; 149(9):6315-6328. PubMed ID: 36745223 [TBL] [Abstract][Full Text] [Related]
8. Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome. Tiraboschi C; Gentilini L; Velazquez C; Corapi E; Jaworski FM; Garcia Garcia JD; Rondón Y; Chauchereau A; Laderach DJ; Compagno D J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33293356 [TBL] [Abstract][Full Text] [Related]
9. Tumor-derived nanovesicles enhance cancer synergistic chemo-immunotherapy by promoting cGAS/STING pathway activation and immunogenetic cell death. Guo Y; Qian R; Li Z; Lv T; Yang C; Li W; Pan T; Hou X; Wang Z Life Sci; 2024 Jul; 348():122687. PubMed ID: 38718856 [TBL] [Abstract][Full Text] [Related]
10. Tumor acidity-activatable macromolecule autophagy inhibitor and immune checkpoint blockade for robust treatment of prostate cancer. Wang Y; Lei H; Yan B; Zhang S; Xu B; Lin M; Shuai X; Huang J; Pang J Acta Biomater; 2023 Sep; 168():593-605. PubMed ID: 37474083 [TBL] [Abstract][Full Text] [Related]
11. PAK4 inhibition improves PD1 blockade immunotherapy in prostate cancer by increasing immune infiltration. Su S; You S; Wang Y; Tamukong P; Quist MJ; Grasso CS; Kim HL Cancer Lett; 2023 Feb; 555():216034. PubMed ID: 36509363 [TBL] [Abstract][Full Text] [Related]
12. Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancer. Liu C; Wang X; Qin W; Tu J; Li C; Zhao W; Ma L; Liu B; Qiu H; Yuan X Cancer Commun (Lond); 2023 Apr; 43(4):435-454. PubMed ID: 36855844 [TBL] [Abstract][Full Text] [Related]
13. TTK inhibition activates STING signal and promotes anti-PD1 immunotherapy in breast cancer. Hu X; Li G; Li S; Wang Q; Wang Y; Zhang P; Yang T; Yang B; Yu L; Liu Z Biochem Biophys Res Commun; 2024 Jan; 694():149388. PubMed ID: 38150917 [TBL] [Abstract][Full Text] [Related]
15. Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma. Wang-Bishop L; Wehbe M; Shae D; James J; Hacker BC; Garland K; Chistov PP; Rafat M; Balko JM; Wilson JT J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169869 [TBL] [Abstract][Full Text] [Related]
16. Ultrasound combined with nanobubbles promotes systemic anticancer immunity and augments anti-PD1 efficacy. Hu J; He J; Wang Y; Zhao Y; Fang K; Dong Y; Chen Y; Zhang Y; Zhang C; Wang H; Tan J; Wang J; Zi R; Liu C; Liang H; Guo Y; Ou J J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35236741 [TBL] [Abstract][Full Text] [Related]
17. Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME). Bretz AC; Parnitzke U; Kronthaler K; Dreker T; Bartz R; Hermann F; Ammendola A; Wulff T; Hamm S J Immunother Cancer; 2019 Nov; 7(1):294. PubMed ID: 31703604 [TBL] [Abstract][Full Text] [Related]
18. A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade. Zhang X; Tian H; Chen Y; Liang B; Nice EC; Huang C; Xie N; Zheng S J Nanobiotechnology; 2024 Sep; 22(1):592. PubMed ID: 39343911 [TBL] [Abstract][Full Text] [Related]
19. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis. Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026 [TBL] [Abstract][Full Text] [Related]